?Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293)
重組SARS冠狀病毒2 Spike突變蛋白S1 (D614G)(His-Avi)
| 英文名稱 | Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293) |
| 中文名稱 | 重組SARS冠狀病毒2 Spike突變蛋白S1 (D614G)(His-Avi) |
| 別????名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(D614G), Recombinant (His-Avi Tag); Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293)??突變型新冠蛋白; 新冠病毒S蛋白突變體（D614G）; 重組新冠病毒 Spike突變蛋白RBD(D614G); 新型冠狀病毒Spike突變體蛋白; |
| 理論分子量 | 77.9kDa |
| 檢測分子量 | 110-130 kDa |
| 性????狀 | Lyophilized or Liquid |
| 濃????度 | ＞0.5 mg/ml |
| 物????種 | SARS-Cov-2 |
| 序????列 | 14-683/1273 |
| 純????度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內(nèi)毒素 | Not analyzed |
| 表達(dá)系統(tǒng) | HEK293 cell |
| 活性 | Yes |
| 標(biāo)簽 | His & Avi |
| 緩?沖?液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4). Normally 5% trehalose is added as protectant before lyophilization. |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct |
本產(chǎn)品僅供科研使用.請勿用于醫(yī)藥,不能用于臨床治療診斷使用！